跳转至内容
Merck
CN

05-599

抗-E1A (Ad2/Ad5)抗体,克隆M73

clone M73, Upstate®, from mouse

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
M73, monoclonal
Application:
ICC, IP, WB
Citations:
18
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


biological source

mouse

Quality Level

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

M73, monoclonal

species reactivity

human

manufacturer/tradename

Upstate®

technique(s)

immunocytochemistry: suitable, immunoprecipitation (IP): suitable, western blot: suitable

isotype

IgG2aκ

NCBI accession no.

UniProt accession no.

shipped in

wet ice

target post-translational modification

unmodified

General description

36-50kDa

Immunogen

从大肠埃希菌中分离的trpE-Ad2 E1A融合蛋白

Application

用抗E1A (Ad2/Ad5)抗体,克隆M73(小鼠单克隆抗体)检测E1A (Ad2/Ad5),该抗体经证明可在IP、WB、ICC中发挥作用。
研究子类别
转录因子
研究类别
表观遗传学&核功能

Biochem/physiol Actions

三种腺病毒(Ad)2和5 E1A基因产物

Physical form

0.05M磷酸钠(pH 7.4)、0.1%叠氮化钠和0.2%明胶
形式:纯化
蛋白A层析

Preparation Note

在4°C下保存1年

Analysis Note

通过免疫印迹对HEK293细胞的RIPA裂解液进行了常规评估

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。


Still not finding the right product?

试用我们的 产品选型工具 工具缩小选择范围


存储类别

12 - Non Combustible Liquids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA.
M von Knebel Doeberitz,C Rittmuller,H zur Hausen,M Durst
International Journal of Cancer. Journal International Du Cancer null
Tamara Nowling et al.
The Journal of biological chemistry, 278(16), 13696-13705 (2002-12-19)
Distal enhancers commonly regulate gene expression. However, the mechanisms of transcriptional mediation by distal enhancers remain largely unknown. To better understand distal enhancer-mediated transcription, we examined the regulation of the FGF-4 gene. The FGF-4 gene is regulated during early development
Eiji Toyoda et al.
Journal of experimental & clinical cancer research : CR, 27, 30-30 (2008-08-23)
To develop a novel therapeutic strategy for human pancreatic cancer using a midkine promoter-based conditionally replicating adenovirus. We examined midkine mRNA expression and midkine protein expression by seven human pancreatic cancer cell lines (AsPC-1, BxPC-3, CFPAC-1, HPAC, MIAPaCa-2, PANC-1, and